tirzepatide dosage 10mg Flex-Dose 3 mL Injectable 10 mg/mL tirzepatide 10 mg vial dosage

Women should understand that whilst probiotics are generally considered safe, their use in this context is based on theoretical benefits and general digestive health support rather than proven efficacy for GLP-1-related symptoms

If cholelithiasis is suspected, gallbladder diagnostic studies and appropriate clinical follow-up are indicated Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include: pain in your upper stomach (abdomen) fever yellowing of skin or eyes (jaundice) clay-colored stools Low Blood Sugar (Hypoglycemia) Your risk for getting low blood sugar may be higher if you use MOUNJARO with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin Signs and symptoms of low blood sugar may include: dizziness or light-headedness sweating confusion or drowsiness headache blurred vision slurred speech shakiness fast heartbeat anxiety, irritability, or mood changes hunger weakness feeling jittery Concomitant use with an insulin secretagogue (e.g., sulfonylurea) or insulin may increase the risk of hypoglycemia, including severe hypoglycemia The risk of hypoglycemia may be lowered by reducing the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin

The practical advice for managing a dose increase well: take the injection on a day when you have the following day relatively free, particularly in the first week at a new dose

Sodium retention is reduced

This helps reduce snacking between meals